Function Oncology and Volastra Therapeutics Form Strategic Partnership to Enhance Precision Cancer Treatment

-Function Oncology, a company transforming the operating system of precision medicine with CRISPR-powered platform technology, today announced an innovativ...

March 27, 2024 | Wednesday | News
Exothera Expands World-First Continuous-Batch RNA Manufacturing Solution to North America to Accelerate RNA Therapies

Game-changing continuous-batch production of RNA service removes process development and scale-up steps through automation and significantly cuts clinical ...

March 27, 2024 | Wednesday | News
Positive CHMP Opinions for Bempedoic Acid and Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet

    “We are thrilled with the positive CHMP opinion, which reflects the significant cardiovascular risk reduction benefit that the bemped...

March 25, 2024 | Monday | News
Elegen Launches ENFINIA™ DNA Enhancement Enabling Rapid Synthesis of Highly Complex DNA

    Gilles Besin, Ph.D., CSO at Orbital: “Elegen's unique expertise in supplying...IVT-ready synthetic DNA constructs is very attractive ...

March 21, 2024 | Thursday | News
Fractyl Health's RJVA-001 Shows Significant Promise in Preclinical Trials for Metabolic Control

Data provides first demonstration of glucose lowering and weight loss potency from pancreas-produced native human GLP-1, highlighting the capacity of pancr...

March 13, 2024 | Wednesday | News
Oxford Nanopore Launches PromethION 2 Integrated Sequencing Device

Oxford Nanopore Technologies announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated (P2i) to complete ...

March 08, 2024 | Friday | News
Biogen Announces Positive Interim Biomarker Data from RESPOND Study at MDA Conference

  Dr. Crystal Proud, Pediatric Neurologist at Children’s Hospital of the King’s Daughters, remarked, “Our evolving understanding of...

March 06, 2024 | Wednesday | News
Biocon Biologics Gains Rights to Launch Stelara® Biosimilar in the US by 2025 Following Janssen Settlement

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced...

March 04, 2024 | Monday | News
Atara Biotherapeutics Secures FDA Nod for Pioneering Lupus Nephritis Treatment

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to d...

March 01, 2024 | Friday | News
BeiGene Reports BRUKINSA® Outperforms Acalabrutinib in Chronic Leukemia Study

BeiGene, Ltd. announced a new matching adjusted indirect comparison (MAIC) of the efficacy of BRUKINSA® (zanubrutinib) versus acalabrutinib in relapsed...

March 01, 2024 | Friday | News
Applied Biomics Launches Anti-Host Cell Protein (HCP) Antibodies with > 95% Coverage

The residual HCPs are generated by organisms used for making recombinant biopharmaceutical products. They are considered as process-related impurities. Sin...

March 01, 2024 | Friday | News
Curve Therapeutics Secures £40.5 Million Series A Funding Led by Pfizer Ventures to Propel Cancer Drug Discovery Efforts

Curve Therapeutics, a pioneering biotechnology firm, announced a significant £40.5 million Series A funding round, led by Pfizer Ventures and joined ...

February 28, 2024 | Wednesday | News
QIAGEN Introduces AI-Powered Biomedical Database to Boost Drug Discovery

QIAGEN announced the launch of QIAGEN Biomedical KB-AI, a new generative AI-driven knowledge base designed to propel drug discovery in the pharma and biote...

February 28, 2024 | Wednesday | News
Viatris and Idorsia Forge Major Global R&D Alliance to Enhance Innovative Drug Portfolio

    Expands Viatris' Portfolio of Innovative Assets by Immediately Adding Two Phase 3 Assets, Selato...

February 28, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close